Creditors of Braskem have turned down another restructuring proposal from the Brazilian petrochemical producer and its controlling shareholders, pushing talks toward a pivotal Oct. 9 deadline to rework roughly $11 billion of debt, according to people familiar with the matter.

The rejection, first reported by Bloomberg News, leaves one of Latin America's largest industrial companies and its two dominant owners — the engineering group Novonor, formerly Odebrecht, and state-controlled oil major Petrobras — with little time to bridge a widening gap with bondholders and bank lenders. In place of the company's offer, creditors are seeking a $3 billion equity injection from the controlling holders, a demand carried in separate market reports from MSN and Yahoo Finance.

Neither Braskem nor its shareholders have commented publicly on the substance of the negotiations, and the precise terms of the rejected proposal have not been disclosed.

A Deal That Keeps Slipping Away

The standoff is not a sudden rupture. Talks over Braskem's capital structure have been grinding on for months, with successive proposals failing to win enough support from a creditor group large enough to make a restructuring work. The Oct. 9 date now functions as the de facto line in the sand: either the parties agree on a framework to extend, reprice, or partially convert the debt, or the company faces the prospect of a more adversarial process.

The $11 billion figure reflects a balance sheet built up over years of expansion across Brazil, the United States, Mexico, and Europe, now weighed down by borrowing that looks increasingly heavy against a softer earnings base.

The $3 Billion Demand

The creditors' central ask — a $3 billion cash infusion from Novonor and Petrobras — is a familiar lever in distressed restructurings. Lenders argue that equity from owners, rather than further concessions from creditors, is the clearest signal that the controlling shareholders retain confidence in the business and will share the pain of any write-downs.

Creditors are pressing Braskem's controlling shareholders to inject roughly $3 billion in new equity as a condition of any restructuring, according to reports — a demand that shifts the burden of adjustment away from lenders and onto the owners.

For Novonor, that demand is awkward. The former Odebrecht has spent years selling assets to manage liabilities stemming from the Lava Jato corruption scandal and has been trying to exit Braskem entirely, holding talks in recent years with suitors including Abu Dhabi's ADNOC — a transaction that valued its stake at roughly $2.1 billion before it collapsed. Asking Novonor for fresh cash is close to asking it for money it has been trying to raise by selling the same asset.

Petrobras presents a different problem. The state-controlled producer has its own capital discipline priorities, a sprawling investment program, and a board attentive to political scrutiny. Writing a multi-billion-dollar check to shore up a chemicals affiliate would invite questions from investors and policymakers alike.

How the Story Was Framed

The coverage has broken along different emphases. Bloomberg led with creditor resistance and the looming deadline, framing the story as a high-stakes negotiation nearing expiry. MSN foregrounded the creditors' demand itself, positioning the $3 billion injection as the headline grievance. Yahoo Finance's market-chatter items stressed the same capital call from controlling holders — one of the two items appeared to be a near-duplicate aggregation of the same wire copy, a common artifact of automated financial feeds.

Taken together, the reports describe the same underlying shift: the initiative has moved from Braskem and its owners to its lenders, who are now setting terms rather than responding to them.

A Company Already Under Pressure

Braskem's financial strain sits atop a broader set of challenges. Global petrochemical margins have been squeezed by a wave of new capacity in Asia and the Middle East, while Brazilian demand has been sluggish. Cheap imported resin has pressured domestic pricing, and the company's leverage has drawn scrutiny from rating agencies.

The company also continues to manage the consequences of geological subsidence in Maceió, Alagoas, where decades of rock-salt mining caused neighborhoods to sink. Compensation and remediation obligations tied to that episode have weighed on Braskem's finances and reputation, and remain a live consideration for any investor evaluating the equity.

What Happens Next

• An agreement before Oct. 9: Creditors win the equity commitment, or something close to it, and the debt is extended or partially converted.
• A short extension: The deadline slips as the parties haggle over the size and timing of any injection — the most common outcome in negotiations of this size.
• No deal: Creditors could pursue more aggressive remedies, raising the risk of a formal default process and deepening uncertainty for suppliers, employees, and Brazilian credit markets.

The stakes extend beyond Braskem's balance sheet. The company is a linchpin of Brazil's industrial supply chain and a significant employer, and its fate touches Petrobras's credibility as a steward of minority-held assets. For creditors, the calculation is straightforward: they hold the debt, and they intend to be paid — or to be convinced that the owners are paying alongside them.